CMPX · Compass Therapeutics, Inc.
AI read · Bad for CMPX
The AI's read
Losing its Nasdaq listing could make CMPX shares harder to trade and weaken confidence in the company. The warning does not remove CMPX from Nasdaq now. It has until May 18, 2027, and may qualify for another 180 days, but the filing says success is not assured.